29.79
Schlusskurs vom Vortag:
$29.42
Offen:
$29.68
24-Stunden-Volumen:
20,684
Relative Volume:
0.09
Marktkapitalisierung:
$1.32B
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+0.99%
1M Leistung:
+29.39%
6M Leistung:
+275.35%
1J Leistung:
+0.00%
Sionna Therapeutics Inc Stock (SION) Company Profile
Firmenname
Sionna Therapeutics Inc
Sektor
Branche
Telefon
617-819-2020
Adresse
21 HICKORY DRIVE, SUITE 500, WALTHAM
Vergleichen Sie SION mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
SION
Sionna Therapeutics Inc
|
29.92 | 1.30B | 0 | 0 | 0 | 0.00 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
407.74 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
461.18 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
550.12 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
![]()
ARGX
Argen X Se Adr
|
800.40 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
![]()
ONC
Beone Medicines Ltd Adr
|
329.04 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Sionna Therapeutics Inc Stock (SION) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-09-03 | Eingeleitet | RBC Capital Mkts | Sector Perform |
2025-09-03 | Eingeleitet | Raymond James | Strong Buy |
2025-03-04 | Eingeleitet | Guggenheim | Buy |
2025-03-04 | Eingeleitet | Stifel | Buy |
2025-03-04 | Eingeleitet | TD Cowen | Buy |
Sionna Therapeutics Inc Aktie (SION) Neueste Nachrichten
What analysts say about Sionna Therapeutics Inc stockReal-Time Stock Alerts & Free Stock Trading Workshops - earlytimes.in
Why hedge funds are buying Sionna Therapeutics Inc. stockQuarterly Profit Summary & AI Enhanced Trade Execution Alerts - newser.com
Sionna Therapeutics (NASDAQ:SION) Trading Up 6%What's Next? - MarketBeat
What indicators show strength in Sionna Therapeutics Inc.2025 Year in Review & Smart Money Movement Tracker - newser.com
Will Sionna Therapeutics Inc. bounce back from current support2025 Buyback Activity & Precise Buy Zone Tips - newser.com
What momentum indicators show for Sionna Therapeutics Inc. stockEntry Point & Long-Term Capital Growth Strategies - newser.com
Sionna Therapeutics (NASDAQ:SION) Receives "Sell (D)" Rating from Weiss Ratings - MarketBeat
Sionna Therapeutics (NASDAQ:SION) Stock Price Down 3.5% After Insider Selling - MarketBeat
Insider Selling: Sionna Therapeutics (NASDAQ:SION) Director Sells 11,800 Shares of Stock - MarketBeat
Only Mass. biotech to go public this year grows headcount 71% - NBC Boston
Sionna Therapeutics Inc. stock trend outlook and recovery pathPortfolio Performance Report & Low Drawdown Momentum Trade Ideas - newser.com
Detecting price anomalies in Sionna Therapeutics Inc. with AIEntry Point & High Return Trade Guides - newser.com
Live market analysis of Sionna Therapeutics Inc.CPI Data & Free Community Supported Trade Ideas - newser.com
Using flow based indicators on Sionna Therapeutics Inc.Risk Management & Weekly High Return Stock Opportunities - newser.com
Multi factor analysis applied to Sionna Therapeutics Inc.July 2025 News Drivers & Expert-Curated Trade Recommendations - newser.com
Sionna Therapeutics (SION): Exploring Valuation After Recent 15% Share Price Climb - Sahm
Statistical indicators supporting Sionna Therapeutics Inc.’s strengthWeekly Trade Analysis & Weekly High Conviction Ideas - newser.com
Will Sionna Therapeutics Inc. stock deliver strong dividend growth2025 Macro Impact & Daily Entry Point Trade Alerts - newser.com
Sionna Therapeutics (NASDAQ:SION) Shares Gap Down Following Insider Selling - Defense World
How currency fluctuations impact Sionna Therapeutics Inc. stockMarket Trend Review & Smart Allocation Stock Reports - newser.com
Sionna Therapeutics director sells shares worth $2.37 million By Investing.com - Investing.com South Africa
Sionna Therapeutics (NASDAQ:SION) Shares Down 5.1% After Insider Selling - Defense World
Sionna Therapeutics director sells shares worth $2.37 million - Investing.com
Sionna Therapeutics to Present Data at the 2025 North American Cystic Fibrosis Conference - GlobeNewswire
Finanzdaten der Sionna Therapeutics Inc-Aktie (SION)
Es liegen keine Finanzdaten für Sionna Therapeutics Inc (SION) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):